studies on tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide and blood pressure reduction:

Explore which types of lifestyle, nutrition, or follow-up conversations with your healthcare team might be worth considering

Peripheral neuropathy affects millions of diabetic patients, and emerging data suggests a complex relationship with GLP-1 therapy

The novel synergistically acting glucagon-like peptide-1 (GLP-1) receptor agonist combined with the amylin agonist, CagriSema, shows promising results in both glucose regulation and weight management

Before taking Mounjaro and oral birth control, speak with your doctor about potential medication absorption issues

For GLP-1 users who are sensitive to heat, prone to nausea, or just starting out with sauna therapy, infrared saunas offer an easier entry point

Find out what happens during week 3 on GLP-1 medications, including what to expect and why it takes a few weeks to feel the full effects.